A research team led by the Guangzhou Institutes of Biomedicine and Health of the Chinese Academy of Sciences has constructed ...

Organogenesis Holdings Inc.’s ORGO share price has surged by 11.07%, which has investors questioning if this is right time to sell.

Organogenesis experienced a significant stock price surge following strong Q4 2024 earnings, but the run-up appears overdone with limited near-term upside. CMS reimbursement uncertainties and ...

Over the last 7 days, the United States market has experienced a 10% decline, contributing to an overall drop of 3.8% over the past year, although earnings are anticipated to grow by 14% annually in ...

As the U.S. stock market grapples with volatility driven by escalating trade tensions and significant index declines, investors are increasingly seeking stability amid uncertainty. In this climate, ...

Virtu Financial LLC acquired a new position in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) in the fourth quarter, ...

Immediate use for the newly developed assembloids could include studying neurodevelopmental disorders such as autism.

A scientific team has used millions of human cells to build neural circuits in the laboratory that sense painful stimuli and ...

From a pinprick to a warm breeze, every sensation you perceive begins its journey along this ascending sensory pathway. For the first time, scientists have recreated the entire human nervous system’s ...

CMS issued the following statement on Local Coverage Determination for certain skin substitute grafts: “As part of the transition to a new ...

Human-induced pluripotent stem cells (hiPSCs) have shown remarkable potential in various applications including cell therapy, regenerative medicine, and ...